Copy number variations in epilepsy plus

Takeaway

  • Pathogenic autosomal copy number variations (CNVs) were identified in 10.9% of patients with epilepsy plus (epilepsy with comorbid features) which rose to 12.7% when considering possibly pathogenic CNVs using a systematic filtering workflow adapted to epilepsy.

Why this matters ?

  • Diagnostic algorithm including CNV detection should be considered in patients with epilepsy plus; this may lead to novel declaration of pathogenicity and promote discovery of promising candidate epilepsy genes.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.